DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR MINOXIDIL EXTRA STRENGTH (FOR MEN)
» See Plans and Pricing
505(b)(2) Clinical Trials for Minoxidil Extra Strength (for Men)
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| OTC | NCT01325337 | Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia | Completed | Allergan | Phase 2 | 2011-06-01 | This study will evaluate the safety and efficacy of 3 doses of bimatoprost solution compared with vehicle and over-the-counter (OTC) minoxidil 5% solution in men with androgenic alopecia. All treatments will be provided in a double-blinded fashion except for minoxidil 5% solution which will be provided open-label. |
| OTC | NCT01325350 | Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss | Completed | Allergan | Phase 2 | 2011-06-01 | This study will evaluate the safety and efficacy of 3 doses of bimatoprost solution compared with vehicle and over-the-counter (OTC) minoxidil 2% solution in women with female pattern hair loss. All treatments will be provided in a double-blinded fashion except for minoxidil 2% solution which will be provided open-label. |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for Minoxidil Extra Strength (for Men)
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00007592 | Hypertension Screening and Treatment Program | Completed | VA Office of Research and Development | N/A | 1989-06-01 | Hypertension is one of the most common medical problems in the United States and in the VA health care system. It has been well-documented that hypertension can be effectively treated. However, there remain important unresolved clinical questions in the area of antihypertensive treatment. For example, how much is mortality affected by visit compliance, blood pressure control and type of antihypertensive agent? Or, are some regimens associated with more morbidity than others? Or, are there inexpensive regimens that are as effective as more expensive regimens? The amount of data that is available from this demonstration project (currently 6,100 patients) will help address these questions. The answers to these questions should result in better care for veterans with hypertension. |
| NCT00151515 | A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss | Completed | Johnson & Johnson Consumer and Personal Products Worldwide | Phase 3 | 2003-10-01 | The primary purpose of the study is to evaluate the efficacy of a topical 5% minoxidil formulation in males for the treatment of pattern hair loss. The secondary purpose is to evaluate the safety of a topical 5% minoxidil formulation in males when used twice daily for the treatment of pattern hair loss and to obtain the safety data on the investigational product when used twice daily for up to one year. |
| NCT00175617 | Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss | Unknown status | University of British Columbia | Phase 2 | 2005-09-01 | This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss. |
| NCT00418730 | Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss | Completed | Neosil, Inc. | Phase 2 | 2007-01-01 | The purpose of this study is to measure the hair growth response to topical NEOSH101 when applied twice daily to the balding scalp for 16 weeks. One hundred eighty men with Norwood/Hamilton grades III-IV with thinning in the top and center of the scalp will participate. Three equally sized treatment groups (60 men each) will receive either topical NEOSH101 2.0%, minoxidil 5%, or placebo. |
| NCT00607477 | Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension | Terminated | University of Chicago | N/A | 2008-01-01 | The purpose of this study is to describe the length of time and extent of blood pressure response to minoxidil and hydralazine among cancer patients with difficult-to-treat vascular endothelial growth factor (VEGF) inhibitor treatment induced hypertension. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Minoxidil Extra Strength (for Men)
Condition Name
Condition MeSH
Clinical Trial Locations for Minoxidil Extra Strength (for Men)
Trials by Country
Clinical Trial Progress for Minoxidil Extra Strength (for Men)
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Minoxidil Extra Strength (for Men)
Sponsor Name
